- Home
- BKNG vs ABT Comparison
BKNG vs ABT Comparison
Compare BKNG & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKNG | ABT |
|---|---|---|
| Founded | 1997 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.8B | 189.6B |
| IPO Year | 1998 | 2006 |
Fundamental Metrics
Financial Performance| Metric | BKNG | ABT |
|---|---|---|
| Price | $4,251.86 | $108.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 29 | 16 |
| Target Price | ★ $5,886.00 | $139.38 |
| AVG Volume (30 Days) | 536.7K | ★ 6.8M |
| Earning Date | 05-21-2026 | 04-23-2026 |
| Dividend Yield | 0.97% | ★ 2.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 165.57 | 3.72 |
| Revenue | $26,917,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $13.36 | $8.92 |
| Revenue Next Year | $8.53 | $7.39 |
| P/E Ratio | ★ $26.12 | $29.64 |
| Revenue Growth | ★ 13.39 | 5.67 |
| 52 Week Low | $3,765.45 | $105.27 |
| 52 Week High | $5,837.03 | $137.49 |
Technical Indicators
Market Signals| Indicator | BKNG | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 36.87 |
| Support Level | $3,765.45 | $105.27 |
| Resistance Level | $5,566.21 | $113.76 |
| Average True Range (ATR) | 140.17 | 1.98 |
| MACD | 48.35 | -0.32 |
| Stochastic Oscillator | 56.19 | 3.77 |
Price Performance
Historical ComparisonAbout BKNG Booking Holdings Inc.
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airlines, rental cars, restaurants, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, Kayak, and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.